Insider Transactions in Q2 2021 at Point Biopharma Global Inc. (PNT)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2021
|
Neil E. Fleshner Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
233,529
+50.0%
|
-
|
|
Jun 30
2021
|
Neil E. Fleshner Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,587,249
+50.0%
|
-
|
|
Jun 30
2021
|
Jonathan R. Goodman Director |
BUY
Grant, award, or other acquisition
|
Indirect |
35,872
+50.0%
|
-
|
|
Jun 30
2021
|
Jonathan R. Goodman Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,523
+50.0%
|
-
|
|
Jun 30
2021
|
Michael M. Gottlieb Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,156,887
+50.0%
|
-
|
|
Jun 30
2021
|
Joe A. Mccann Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,614,153
+50.0%
|
-
|
|
Jun 30
2021
|
Allan C Silber Executive Chairman |
BUY
Grant, award, or other acquisition
|
Indirect |
4,645,486
+50.0%
|
-
|
|
Jun 30
2021
|
Allan C Silber Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
4,218,605
+50.0%
|
-
|
|
Jun 29
2021
|
Peter Kolchinsky Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
209,100
+15.99%
|
$2,091,000
$10.0 P/Share
|
|
Jun 29
2021
|
Ra Capital Management, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
209,100
+15.99%
|
$2,091,000
$10.0 P/Share
|
|
Jun 24
2021
|
Peter Kolchinsky Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
889,218
+50.0%
|
$8,892,180
$10.0 P/Share
|